KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Return on Equity (2020 - 2025)

Clover Health Investments' Return on Equity history spans 6 years, with the latest figure at 0.0% for Q3 2025.

  • For Q3 2025, Return on Equity fell 1.0% year-over-year to 0.0%; the TTM value through Sep 2025 reached 0.0%, down 1.0%, while the annual FY2024 figure was 0.01%, 2.0% up from the prior year.
  • Return on Equity reached 0.0% in Q3 2025 per CLOV's latest filing, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 17.67% in Q1 2021 to a low of 1.46% in Q3 2021.
  • Average Return on Equity over 5 years is 0.46%, with a median of 0.07% recorded in 2023.
  • Peak YoY movement for Return on Equity: crashed -1885bps in 2022, then soared 103bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 1.34% in 2021, then skyrocketed by 43bps to 0.77% in 2022, then soared by 99bps to 0.01% in 2023, then skyrocketed by 191bps to 0.01% in 2024, then crashed by -119bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Return on Equity are 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025).